Michael J. Zema

973 total citations
38 papers, 667 citations indexed

About

Michael J. Zema is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael J. Zema has authored 38 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael J. Zema's work include Cardiac electrophysiology and arrhythmias (11 papers), Cardiac Imaging and Diagnostics (10 papers) and Lipoproteins and Cardiovascular Health (7 papers). Michael J. Zema is often cited by papers focused on Cardiac electrophysiology and arrhythmias (11 papers), Cardiac Imaging and Diagnostics (10 papers) and Lipoproteins and Cardiovascular Health (7 papers). Michael J. Zema collaborates with scholars based in United States, Italy and Canada. Michael J. Zema's co-authors include Paul Kligfield, Salvatore A. Chiaramida, Mitchell Goldman, Donald Margouleff, Susan Kline, Kenneth W. Sniderman, T A Sos, Roy A. Pizzarello, John Morrison and Lawrence Scherr and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Michael J. Zema

37 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Zema United States 17 454 228 171 100 79 38 667
Takashi Tanigawa Japan 16 507 1.1× 222 1.0× 226 1.3× 88 0.9× 42 0.5× 59 781
Stella M. Macı́n Argentina 13 631 1.4× 186 0.8× 120 0.7× 120 1.2× 44 0.6× 42 778
Andrew H. Maslowski New Zealand 6 623 1.4× 338 1.5× 205 1.2× 39 0.4× 22 0.3× 8 732
Tonya R. Edens United States 8 708 1.6× 180 0.8× 69 0.4× 67 0.7× 54 0.7× 8 791
Evdokia N. Adamopoulou Greece 13 433 1.0× 353 1.5× 70 0.4× 207 2.1× 89 1.1× 22 682
Noreen Dolan United States 9 869 1.9× 215 0.9× 76 0.4× 75 0.8× 57 0.7× 12 940
Donatella Ruggiero Italy 13 389 0.9× 188 0.8× 116 0.7× 59 0.6× 134 1.7× 19 645
Harry T. Colfer United States 9 351 0.8× 237 1.0× 217 1.3× 34 0.3× 22 0.3× 11 533
Eduardo Perna Argentina 14 606 1.3× 144 0.6× 120 0.7× 53 0.5× 61 0.8× 59 753
Michael Shochat Israel 15 330 0.7× 181 0.8× 85 0.5× 60 0.6× 26 0.3× 34 574

Countries citing papers authored by Michael J. Zema

Since Specialization
Citations

This map shows the geographic impact of Michael J. Zema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Zema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Zema more than expected).

Fields of papers citing papers by Michael J. Zema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Zema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Zema. The network helps show where Michael J. Zema may publish in the future.

Co-authorship network of co-authors of Michael J. Zema

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Zema. A scholar is included among the top collaborators of Michael J. Zema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Zema. Michael J. Zema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zema, Michael J.. (2009). Add-on therapy for hypercholesterolemia: a pilot comparison of two gastrointestinally-acting agents in statin-treated patients. Journal of clinical lipidology. 3(2). 119–124. 4 indexed citations
3.
Zema, Michael J.. (2005). Colesevelam HCl and Ezetimibe Combination Therapy Provides Effective Lipid-Lowering in Difficult-to-Treat Patients with Hypercholesterolemia. American Journal of Therapeutics. 12(4). 306–310. 45 indexed citations
4.
Zema, Michael J. & Enoch Chan. (2004). Ezetimibe and Colesevelam are Additive in the Management Of Hypercholesterolemia. CHEST Journal. 126(4). 825S–825S. 2 indexed citations
5.
Bays, Harold, James M. McKenney, Carlos A. Dujovne, et al.. (2003). Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol. The American Journal of Cardiology. 92(5). 538–543. 40 indexed citations
6.
Zema, Michael J.. (2000). Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study. Journal of the American College of Cardiology. 35(3). 640–646. 23 indexed citations
7.
Zema, Michael J., et al.. (1998). [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].. PubMed. 48(5A). 604–12. 1 indexed citations
9.
Zema, Michael J.. (1985). Prognosis After Myocardial Infarction- Prediction in Ambulatory Patients by Use of the Bedside Valsalva Maneuver. Angiology. 36(2). 96–104. 5 indexed citations
10.
Zema, Michael J., et al.. (1984). Dyspnea: The Heart or the Lungs?. CHEST Journal. 85(1). 59–64. 45 indexed citations
11.
Zema, Michael J.. (1984). Serum Drug Concentrations and Adverse Effects in Cardiac Patients After Administration of a New Controlled-Release Disopyramide Preparation. Therapeutic Drug Monitoring. 6(2). 192–198. 12 indexed citations
12.
Zema, Michael J.. (1982). The ECG recognition of concomitant left anterior fascicular block and inferior myocardial infarction. Journal of Electrocardiology. 15(4). 401–402. 3 indexed citations
13.
Zema, Michael J., et al.. (1982). Somatotype and idiopathic mitral valve prolapse. Catheterization and Cardiovascular Diagnosis. 8(2). 105–111. 12 indexed citations
14.
Zema, Michael J., et al.. (1982). Feasibility of detailed M‐mode echocardiographic examination in markedly obese adults: Prospective study of 50 patients. Journal of Clinical Ultrasound. 10(1). 31–34. 13 indexed citations
15.
Zema, Michael J., Margaret Collins, Daniel R. Alonso, & Paul Kligfield. (1981). Electrocardiographic Poor R-Wave Progression. CHEST Journal. 79(2). 195–200. 27 indexed citations
16.
Zema, Michael J., et al.. (1980). Left ventricular dysfunction--bedside Valsalva manoeuvre.. Heart. 44(5). 560–569. 69 indexed citations
17.
Morrison, John, et al.. (1980). Correlation of radionuclide estimates of myocardial infarction size and release of creatine kinase-MB in man.. Circulation. 62(2). 277–287. 45 indexed citations
18.
Chiaramida, Salvatore A., et al.. (1980). Real‐time cross‐sectional echocardiographic diagnosis of infiltrative cardiomyopathy due to amyloid. Journal of Clinical Ultrasound. 8(1). 58–62. 31 indexed citations
19.
Morrison, John, James Coromilas, Lawrence Ong, et al.. (1980). Digitalis and myocardial infarction in man.. Circulation. 62(1). 8–16. 34 indexed citations
20.
Zema, Michael J. & Paul Kligfield. (1979). Electrocardiographic poor R wave progression I: Correlation with the Frank vectorcardiogram. Journal of Electrocardiology. 12(1). 3–10. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026